Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma

ConclusionMetformin may be associated with increased tumor response after Y-90 RS in patients with HCC.Level of EvidenceIII, Retrospective Study.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research